BIOMEA FUSION INC (BMEA) Fundamental Analysis & Valuation

NASDAQ:BMEA • US09077A1060

Current stock price

1.87 USD
+0.02 (+1.08%)
At close:
1.82 USD
-0.05 (-2.67%)
After Hours:

This BMEA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BMEA Profitability Analysis

1.1 Basic Checks

  • BMEA had negative earnings in the past year.
  • BMEA had a negative operating cash flow in the past year.
  • BMEA had negative earnings in each of the past 5 years.
  • BMEA had a negative operating cash flow in each of the past 5 years.
BMEA Yearly Net Income VS EBIT VS OCF VS FCFBMEA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -50M -100M

1.2 Ratios

  • BMEA's Return On Assets of -105.51% is on the low side compared to the rest of the industry. BMEA is outperformed by 77.37% of its industry peers.
  • Looking at the Return On Equity, with a value of -209.11%, BMEA is doing worse than 70.41% of the companies in the same industry.
Industry RankSector Rank
ROA -105.51%
ROE -209.11%
ROIC N/A
ROA(3y)-112.44%
ROA(5y)-84.6%
ROE(3y)-182.27%
ROE(5y)-129.09%
ROIC(3y)N/A
ROIC(5y)N/A
BMEA Yearly ROA, ROE, ROICBMEA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

1.3 Margins

  • BMEA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMEA Yearly Profit, Operating, Gross MarginsBMEA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BMEA Health Analysis

2.1 Basic Checks

  • BMEA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BMEA has been increased compared to 5 years ago.
  • BMEA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BMEA Yearly Shares OutstandingBMEA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
BMEA Yearly Total Debt VS Total AssetsBMEA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • BMEA has an Altman-Z score of -11.65. This is a bad value and indicates that BMEA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -11.65, BMEA is doing worse than 75.82% of the companies in the same industry.
  • There is no outstanding debt for BMEA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.65
ROIC/WACCN/A
WACCN/A
BMEA Yearly LT Debt VS Equity VS FCFBMEA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M 150M

2.3 Liquidity

  • A Current Ratio of 5.23 indicates that BMEA has no problem at all paying its short term obligations.
  • BMEA has a Current ratio (5.23) which is in line with its industry peers.
  • BMEA has a Quick Ratio of 5.23. This indicates that BMEA is financially healthy and has no problem in meeting its short term obligations.
  • BMEA's Quick ratio of 5.23 is in line compared to the rest of the industry. BMEA outperforms 57.83% of its industry peers.
Industry RankSector Rank
Current Ratio 5.23
Quick Ratio 5.23
BMEA Yearly Current Assets VS Current LiabilitesBMEA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BMEA Growth Analysis

3.1 Past

  • BMEA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.89%, which is quite impressive.
EPS 1Y (TTM)65.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 13.96% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y16.81%
EPS Next 2Y-2.65%
EPS Next 3Y4.81%
EPS Next 5Y13.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMEA Yearly Revenue VS EstimatesBMEA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2030 2031 2032 2033 200M 400M 600M 800M 1B
BMEA Yearly EPS VS EstimatesBMEA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

0

4. BMEA Valuation Analysis

4.1 Price/Earnings Ratio

  • BMEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BMEA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMEA Price Earnings VS Forward Price EarningsBMEA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMEA Per share dataBMEA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.65%
EPS Next 3Y4.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BMEA Dividend Analysis

5.1 Amount

  • BMEA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BMEA Fundamentals: All Metrics, Ratios and Statistics

BIOMEA FUSION INC

NASDAQ:BMEA (4/10/2026, 8:08:16 PM)

After market: 1.82 -0.05 (-2.67%)

1.87

+0.02 (+1.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-24
Earnings (Next)05-04
Inst Owners38.2%
Inst Owner Change0%
Ins Owners3.18%
Ins Owner Change3.91%
Market Cap132.21M
Revenue(TTM)N/A
Net Income(TTM)-61.80M
Analysts83.08
Price Target7.14 (281.82%)
Short Float %18.56%
Short Ratio10.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)100.89%
Min EPS beat(2)-3.47%
Max EPS beat(2)205.25%
EPS beat(4)2
Avg EPS beat(4)44.84%
Min EPS beat(4)-28.2%
Max EPS beat(4)205.25%
EPS beat(8)5
Avg EPS beat(8)24.68%
EPS beat(12)7
Avg EPS beat(12)16.03%
EPS beat(16)8
Avg EPS beat(16)10.67%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)3.38%
EPS NQ rev (3m)3.38%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.47
P/tB 4.47
EV/EBITDA N/A
EPS(TTM)-1.31
EYN/A
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS0
BVpS0.42
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -105.51%
ROE -209.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-112.44%
ROA(5y)-84.6%
ROE(3y)-182.27%
ROE(5y)-129.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.23
Quick Ratio 5.23
Altman-Z -11.65
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y16.81%
EPS Next 2Y-2.65%
EPS Next 3Y4.81%
EPS Next 5Y13.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.4%
EBIT Next 3Y-17.14%
EBIT Next 5YN/A
FCF growth 1Y41.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.31%
OCF growth 3YN/A
OCF growth 5YN/A

BIOMEA FUSION INC / BMEA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIOMEA FUSION INC?

ChartMill assigns a fundamental rating of 2 / 10 to BMEA.


Can you provide the valuation status for BIOMEA FUSION INC?

ChartMill assigns a valuation rating of 0 / 10 to BIOMEA FUSION INC (BMEA). This can be considered as Overvalued.


Can you provide the profitability details for BIOMEA FUSION INC?

BIOMEA FUSION INC (BMEA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for BIOMEA FUSION INC?

The Earnings per Share (EPS) of BIOMEA FUSION INC (BMEA) is expected to grow by 16.81% in the next year.